Nelson Capital Management, LLC Abb Vie Inc. Transaction History

Nelson Capital Management, LLC

$587 Million
Q3 2024

A detailed history of Nelson Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nelson Capital Management, LLC holds 25,682 shares of ABBV stock, worth $4.36 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

25,682

Previous 25,268 1.64%

Holding current value

$4.36 Million

Previous $4.33 Million 17.03%

% of portfolio

0.86%

Previous 0.78%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$163.84 - $199.33 $67,829 - $82,522	414 Added 1.64%	25,682 $5.07 Million
Q2 2024 Aug 07, 2024	SELL	$154.79 - $180.76 $111,603 - $130,327	-721 Reduced 2.77%	25,268 $4.33 Million
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $891,475 - $1.02 Million	5,578 Added 27.33%	25,989 $4.73 Million
Q4 2023 Jan 26, 2024	SELL	$137.6 - $154.97 $557,830 - $628,248	-4,054 Reduced 16.57%	20,411 $3.16 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $39,141 - $45,312	293 Added 1.21%	24,465 $3.65 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $158,746 - $197,550	1,198 Added 5.21%	24,172 $3.26 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $2.59 Million - $2.99 Million	17,933 Added 355.74%	22,974 $3.66 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $39,594 - $49,125	-300 Reduced 5.62%	5,041 $817,000
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $26,600 - $30,195	-250 Reduced 4.47%	5,341 $576,000
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $256,261 - $282,113	-2,505 Reduced 30.94%	5,591 $605,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $12,886 - $15,124	-150 Reduced 1.82%	8,096 $709,000
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $63,611 - $85,122	-867 Reduced 9.51%	8,246 $810,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $87,060 - $108,931	-1,207 Reduced 11.7%	9,113 $807,000
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $62,980 - $75,720	1,000 Added 10.73%	10,320 $781,000
Q2 2019 Jul 25, 2019	SELL	$65.7 - $83.98 $13,140 - $16,796	-200 Reduced 2.1%	9,320 $678,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $115,478 - $135,912	-1,497 Reduced 13.59%	9,520 $767,000
Q4 2018 Jan 30, 2019	SELL	$77.85 - $96.01 $2,335 - $2,880	-30 Reduced 0.27%	11,017 $1.02 Million
Q3 2018 Oct 09, 2018	BUY	$88.91 - $98.84 $2,667 - $2,965	30 Added 0.27%	11,047 $1.05 Million
Q2 2018 Jul 17, 2018	BUY	$89.78 - $106.23 $59,883 - $70,855	667 Added 6.44%	11,017 $1.02 Million
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $22,082 - $29,570	-240 Reduced 2.27%	10,350 $980,000
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $530,374 - $581,599	5,922 Added 126.86%	10,590 $1.02 Million
Q2 2017 Aug 11, 2017	BUY	N/A	4,668	4,668 $338,000

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson Capital Management, LLC with notifications on news.

Account

Nelson Capital Management, LLC Abb Vie Inc. Transaction History